RNLX
Income statement / Annual
Last year (2024), Renalytix Plc's total revenue was $2.29 M,
a decrease of 32.74% from the previous year.
In 2024, Renalytix Plc's net income was -$33.46 M.
See Renalytix Plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
| Operating Revenue |
$2.29 M
|
$3.40 M
|
$2.97 M
|
$1.49 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.13 M |
$2.70 M |
$2.05 M |
$804,000.00 |
$74,000.00 |
$30,994.00 |
$0.00 |
| Gross Profit |
$156,000.00 |
$701,000.00 |
$918,000.00 |
$687,000.00 |
-$74,000.00 |
-$30,994.00 |
$0.00 |
| Gross Profit Ratio |
0.07 |
0.21 |
0.31 |
0.46 |
0 |
0 |
0 |
| Research and Development
Expenses |
$9.29 M
|
$14.30 M
|
$14.65 M
|
$10.04 M
|
$4.57 M
|
$39.60 M
|
$0.00
|
| General & Administrative
Expenses |
$19.75 M
|
$43.06 M
|
$12.95 M
|
$8.37 M
|
$11.08 M
|
$6.54 M
|
$1.25 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$836,000.00
|
| Selling, General &
Administrative Expenses |
$19.75 M
|
$43.06 M
|
$12.95 M
|
$8.37 M
|
$11.08 M
|
$6.54 M
|
$418,000.00
|
| Other Expenses |
$249,000.00 |
$656,000.00 |
$30.69 M |
$14.88 M |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$29.04 M |
$43.06 M |
$58.29 M |
$33.30 M |
$11.08 M |
$6.54 M |
$418,000.00 |
| Cost And Expenses |
$31.17 M |
$45.76 M |
$60.34 M |
$34.10 M |
$11.08 M |
$6.54 M |
$418,000.00 |
| Interest Income |
$0.00 |
$509,000.00 |
$12,000.00 |
$236,000.00 |
$530,000.00 |
$39,000.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$2,000.00 |
$3,000.00 |
$2,000.00 |
$20,000.00 |
$0.00 |
| Depreciation &
Amortization |
$364,000.00
|
$508,000.00
|
$489,000.00
|
$282,000.00
|
$74,000.00
|
$30,999.00
|
$1.25 M
|
| EBITDA |
-$28.52 M
|
-$41.71 M
|
-$52.69 M
|
-$33.69 M
|
-$11.08 M
|
-$5.37 M
|
-$418,000.00
|
| EBITDA Ratio |
-10.28 |
-10.43 |
-15.19 |
-26.43 |
0 |
0 |
0 |
| Operating Income Ratio
|
-12.93
|
-12.45
|
-19.32
|
-21.87
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$3.84 M
|
-$3.38 M
|
$7.93 M
|
-$2.11 M
|
-$295,000.00
|
$535,000.00
|
$0.00
|
| Income Before Tax |
-$33.45 M |
-$46.22 M |
-$49.63 M |
-$35.79 M |
-$10.61 M |
-$6.52 M |
-$418,000.00 |
| Income Before Tax Ratio
|
-14.61
|
-13.58
|
-16.71
|
-24
|
0
|
0
|
0
|
| Income Tax Expense |
$4,000.00 |
$2,000.00 |
$25,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$33.46 M |
-$45.61 M |
-$45.28 M |
-$34.73 M |
-$9.84 M |
-$42.30 M |
-$1.25 M |
| Net Income Ratio |
-14.62 |
-13.4 |
-15.24 |
-23.29 |
0 |
0 |
0 |
| EPS |
-0.31 |
-0.55 |
-0.62 |
-0.49 |
-0.17 |
-0.99 |
-0.03 |
| EPS Diluted |
-0.31 |
-0.55 |
-0.67 |
-0.49 |
-0.17 |
-0.99 |
-0.03 |
| Weighted Average Shares
Out |
$108.18 M
|
$82.21 M
|
$67.98 M
|
$70.87 M
|
$57.91 M
|
$42.56 M
|
$41.80 M
|
| Weighted Average Shares
Out Diluted |
$108.18 M
|
$82.21 M
|
$73.84 M
|
$71.48 M
|
$59.08 M
|
$42.56 M
|
$41.80 M
|
| Link |
|
|
|
|
|
|
|
